T86.5

Clinical Causes: Rejection of transplanted stem cells by the recipient's immune system Graft-versus-host disease (GVHD), where donor cells attack the recipient's tissues Infections due to weakened immune defenses post-transplant Engraftment failure, resulting in the inability of transplanted cells to grow and restore normal blood cell production Organ damage caused by conditioning therapies used before transplantation Side effects from medications used to prevent or treat complications Errors in stem cell collection, processing, or transplantation procedure

Key Symptoms: Fever and chills Fatigue and weakness Unusual bleeding or bruising Signs of infection such as sore throat or persistent cough Skin rashes or itching Diarrhea or abdominal pain Shortness of breath or coughing Jaundice (yellowing of the skin or eyes) Swelling or pain at the transplant site or in various organs Changes in mental status or confusion

Diagnosis Path: Medical professionals diagnose complications using a combination of laboratory tests, physical examinations, and imaging studies. Blood tests can detect abnormalities in blood cell counts or signs of infection. Imaging studies like X-rays, ultrasounds, or CT scans may be used to assess organ health. A biopsy might be performed to evaluate tissue damage or confirm graft-versus-host disease. Monitoring ongoing symptoms and conducting immune function tests are crucial in recognizing potential issues early.

Treatment Protocols: Antibiotics, antifungals, or antivirals to treat or prevent infections Immunosuppressive medications to reduce graft-versus-host disease Supportive care such as blood transfusions or platelet support Medications to modulate immune response or reduce inflammation Nutritional support and physical therapy to improve recovery Organ-specific treatments depending on the affected area Monitoring closely for early signs of complications Adjustments in immunosuppressive therapy based on individual response